7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Acelyrin Inc
(NASDAQ:SLRN) 

SLRN stock logo

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company is headquartered in Agoura Hills, California.

Founded: 2020
IPO Price: $18 (May 05, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Acelyrin Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.18-1.01-0.84-0.67-0.51-0.34-0.170
Acelyrin Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.3-1.12-0.93-0.75-0.56-0.37-0.190
Acelyrin Cash Per Share ttm
202311 202312 202401 202402 202403 202404 01.162.333.494.655.816.988.14
Acelyrin (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -1.72-1.48-1.23-0.98-0.74-0.49-0.250
Acelyrin P/B ratio ttm
202311 202312 202401 202402 202403 202404 -2.15-1.84-1.54-1.23-0.92-0.61-0.310
No extra charts and metrics for this ticker.